| First Author | Ricard N | Year | 2019 |
| Journal | J Exp Med | Volume | 216 |
| Issue | 8 | Pages | 1874-1890 |
| PubMed ID | 31196980 | Mgi Jnum | J:282556 |
| Mgi Id | MGI:6364447 | Doi | 10.1084/jem.20182151 |
| Citation | Ricard N, et al. (2019) Endothelial ERK1/2 signaling maintains integrity of the quiescent endothelium. J Exp Med 216(8):1874-1890 |
| abstractText | To define the role of ERK1/2 signaling in the quiescent endothelium, we induced endothelial Erk2 knockout in adult Erk1(-/-) mice. This resulted in a rapid onset of hypertension, a decrease in eNOS expression, and an increase in endothelin-1 plasma levels, with all mice dying within 5 wk. Immunostaining and endothelial fate mapping showed a robust increase in TGFbeta signaling leading to widespread endothelial-to-mesenchymal transition (EndMT). Fibrosis affecting the cardiac conduction system was responsible for the universal lethality in these mice. Other findings included renal endotheliosis, loss of fenestrated endothelia in endocrine organs, and hemorrhages. An ensemble computational intelligence strategy, comprising deep learning and probabilistic programing of RNA-seq data, causally linked the loss of ERK1/2 in HUVECs in vitro to activation of TGFbeta signaling, EndMT, suppression of eNOS, and induction of endothelin-1 expression. All in silico predictions were verified in vitro and in vivo. In summary, these data establish the key role played by ERK1/2 signaling in the maintenance of vascular normalcy. |
